AUD - Australian Dollar

The Australian dollar crept back above 0.70 US cents through trade on Monday, buoyed by an uptick in risk appetite. Investors chased risk assets higher following reports further COVID-19 vaccine trials showed promising results. AstraZenica, in partnership with Oxford University, released results of trials that covered over 1,000 patients all of whom generated antibodies to the virus as well as T-cells which seek out and kill already infected cells. With no serious side-effects reported researchers will move to the next stage of clinical trials, upsizing the number of participants in the hope of having a finished product ready for delivery to key healthcare workers and those most vulnerable to the disease by years end. Having pushed back through 0.70 the AUD touched intraday highs at 0.7020 before leveling out and trading sideways into this morning’s open.

Attentions remain with the race for a COVID-19 vaccine as risk demand continues to steer direction. With investors largely ignoring the slew of negative data points and dire headlines any sign a vaccine will be ready sooner than first expected will help drive the risk on tone and support a higher AUD. That said, while the dollar has edged higher through the last 2 weeks the AUD has struggled to extend gains beyond 0.7020 with investors reluctant to extend gains amid heightened uncertainty. Current rallies are not supported by the same level of conviction as the rally of April and May and as risk sentiment moderates the threat of a slower economic recovery amid renewed restrictions across Victoria and NSW could prompt a correction leading through Q3 ad Q4.

Key Movers

The USD edged lower through trade on Monday amid a backdrop of optimism driven by positive COVID-19 vaccine trials and a resurgent Euro. The Euro touched four-month highs, jumping above 1.1450 after EU leaders agreed on distributing 390 billion of the 750 billion proposed recovery fund as grants to the worst hit member states while the remaining 360 billion will be parceled into low interest rate loans. The proposed agreement is a huge step forward in a united Europe and bolstered markets hopes the EU will continue to be proactive in tackling the problems raised by the COVID-19 crisis. Having touched intraday highs at 1.1467 the single currency opens marginally lower at 1.1444.

With little of note on the macroeconomic docket this week, attentions remain with fiscal support plans and COVID-19 headlines. Discussions between democrats and republicans regarding a proposed 1 trillion dollar economic relief bill continue through the week with delays possibly adding to safe-haven bids on the dollar.

Expected Ranges

AUD/USD: 0.6930 - 0.7030 ▲
AUD/EUR: 0.6080 - 0.6170 ▲

GBP/AUD: 1.7880 - 1.8120 ▲

AUD/NZD: 1.0520 - 1.0620 ▼

AUD/CAD: 0.9450 - 0.9530 ▼

IMPORTANT: This information has been prepared for distribution over the internet and without taking into account the investment objectives, financial situation and particular needs of any particular person. Oz Forex Foreign Exchange makes no recommendations as to the merits of any financial product referred to in this website, emails or its related websites. Please read our Product Disclosure Statement and our Financial Services Guide.

Regulated in Australia by ASIC (AFS Licence number 226 484)
© 2010 Copyright Oz Forex Foreign Exchange Pty Ltd ABN 65 092-375-703
OzForex Foreign Exchange Services

Member of FOS (Financial Ombudsman Service)
Full Member of AFMA (Australian Financial Markets Association)

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP

AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP

AUD/USD is trading close to 0.6500 in Asian trading on Thursday, lacking a clear directional impetus amid an Anzac Day holiday in Australia. Meanwhile, traders stay cautious due ti risk-aversion and ahead of the key US Q1 GDP release. 

AUD/USD News

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, testing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming Japanese intervention risks. Focus shifts to Thursday's US GDP report and the BoJ decision on Friday. 

USD/JPY News

Gold price treads water near $2,320, awaits US GDP data

Gold price treads water near $2,320, awaits US GDP data

Gold price recovers losses but keeps its range near $2,320 early Thursday. Renewed weakness in the US Dollar and the US Treasury yields allow Gold buyers to breathe a sigh of relief. Gold price stays vulnerable amid Middle East de-escalation, awaiting US Q1 GDP data. 

Gold News

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.

Read more

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance Premium

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance

This must be "opposites" week. While Doppelganger Tesla rode horrible misses on Tuesday to a double-digit rally, Meta Platforms produced impressive beats above Wall Street consensus after the close on Wednesday, only to watch the share price collapse by nearly 10%.

Read more

Majors

Cryptocurrencies

Signatures